Wynberg et al. [33] reported that individuals with post-acute sequelae of SARS-CoV-2 infection (PASC) exhibited elevated IL-10, IL-17, IL-6, IP10, and TNF-α at 24 weeks post-infection, and that early IL-1β levels predicted PASC at 24 weeks. The gene discussed is IL17A; the disease is long COVID-19.